Monash IVF Group
MVF.AX
#7505
Rank
NZ$0.48 B
Marketcap
$1.25
Share price
-0.88%
Change (1 day)
-9.82%
Change (1 year)

P/E ratio for Monash IVF Group (MVF.AX)

P/E ratio at the end of 2023: 20.0

According to Monash IVF Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 19.8557. At the end of 2023 the company had a P/E ratio of 20.0.

P/E ratio history for Monash IVF Group from 2014 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202320.02.23%
202219.672.6%
202111.31.62%
202011.2-29.2%
201915.849.11%
201810.6-14.7%
201712.4-6.14%
201613.29.58%
201512.1-80.83%
201462.9

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.